PHILADELPHIA, March 24, 2022: Morgan Lewis represented ADMA Biologics Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, in connection with a $175 million debt refinancing with Hayfin Capital Management.
Morgan Lewis partner Andrew Budreika, associate Ben Stango, and of counsel Kathleen Martin represented ADMA.